Corcept Therapeutics Incorporated (CORT) — Working Capital to Net Assets Ratio
Corcept Therapeutics Incorporated (CORT) has a Working Capital to Net Assets ratio of 43.4% as of March 2026. Working capital of $276.85 Million (current assets of $426.03 Million minus current liabilities of $149.19 Million) is measured against net assets of $637.99 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Corcept Therapeutics Incorporated to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Corcept Therapeutics Incorporated Working Capital to Net Assets (2003–2025)
This chart shows how Corcept Therapeutics Incorporated's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of March 2026, the ratio stands at 43.4%, reflecting working capital of $276.85 Million against net assets of $637.99 Million USD. Check Corcept Therapeutics Incorporated tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Corcept Therapeutics Incorporated (2003–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Corcept Therapeutics Incorporated from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see CORT market cap.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.3% | $319.38 Million | $647.80 Million | $485.46 Million | $166.09 Million | ▲ +0.6 pp |
| 2024 | 48.7% | $330.83 Million | $679.59 Million | $471.60 Million | $140.77 Million | ▼ -21.2 pp |
| 2023 | 69.9% | $354.13 Million | $506.70 Million | $458.64 Million | $104.50 Million | ▼ -15.2 pp |
| 2022 | 85.0% | $426.76 Million | $501.84 Million | $499.25 Million | $72.49 Million | ▲ +26.8 pp |
| 2021 | 58.3% | $218.92 Million | $375.81 Million | $266.46 Million | $47.54 Million | ▼ -39.9 pp |
| 2020 | 98.2% | $513.69 Million | $523.34 Million | $524.25 Million | $10.55 Million | ▲ +25.8 pp |
| 2019 | 72.3% | $268.52 Million | $371.18 Million | $307.36 Million | $38.84 Million | ▼ -1.9 pp |
| 2018 | 74.2% | $204.78 Million | $275.88 Million | $240.59 Million | $35.81 Million | ▲ +16.1 pp |
| 2017 | 58.1% | $111.03 Million | $190.97 Million | $140.60 Million | $29.57 Million | ▼ -34.5 pp |
| 2016 | 92.6% | $38.31 Million | $41.38 Million | $65.69 Million | $27.37 Million | ▼ -59.3 pp |
| 2015 | 151.9% | $28.10 Million | $18.50 Million | $48.98 Million | $20.88 Million | ▲ +644.1 pp |
| 2014 | -492.2% | $16.68 Million | $-3.39 Million | $30.23 Million | $13.55 Million | ▼ -709.0 pp |
| 2013 | 216.8% | $45.57 Million | $21.02 Million | $58.31 Million | $12.74 Million | ▲ +76.5 pp |
| 2012 | 140.3% | $86.70 Million | $61.78 Million | $95.06 Million | $8.36 Million | ▲ +40.5 pp |
| 2011 | 99.8% | $34.75 Million | $34.81 Million | $39.77 Million | $5.03 Million | ▲ +0.3 pp |
| 2010 | 99.5% | $21.14 Million | $21.24 Million | $25.00 Million | $3.86 Million | ▼ -0.1 pp |
| 2009 | 99.6% | $22.00 Million | $22.09 Million | $24.42 Million | $2.42 Million | ▲ +0.7 pp |
| 2008 | 98.9% | $16.72 Million | $16.91 Million | $19.58 Million | $2.86 Million | ▼ -0.6 pp |
| 2007 | 99.5% | $14.66 Million | $14.73 Million | $17.66 Million | $2.99 Million | ▲ +0.7 pp |
| 2006 | 98.8% | $6.29 Million | $6.36 Million | $9.80 Million | $3.51 Million | ▲ +1.1 pp |
| 2005 | 97.7% | $25.98 Million | $26.59 Million | $29.50 Million | $3.52 Million | ▲ +18.5 pp |
| 2004 | 79.3% | $36.42 Million | $45.95 Million | $38.24 Million | $1.82 Million | ▼ -25.5 pp |
| 2003 | 104.7% | $10.73 Million | $10.24 Million | $11.74 Million | $1.01 Million | — |